Screener
Inspire Medical Systems INSP EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Inspire Medical Systems’s reported figures.
Based on trailing twelve months.
The source filing: Inspire Medical Systems’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001609550-26-000023
FAQ
- What is Inspire Medical Systems's EBITDA margin?
- Inspire Medical Systems (INSP) reported EBITDA margin of 7.4% in Q1 2026.
- How has Inspire Medical Systems's EBITDA margin changed year-over-year?
- Inspire Medical Systems's EBITDA margin increased by 5.5% year-over-year, from 7% to 7.4%.
- What is the long-term trend for Inspire Medical Systems's EBITDA margin?
- Over 4 years (2020 to 2025), Inspire Medical Systems's EBITDA margin has grown at a -37.9% compound annual growth rate (CAGR), from -48% to 7.1%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about Inspire Medical Systems's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude